<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Oral rehydration therapy</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Oral rehydration therapy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Oral rehydration therapy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen Freedman, MDCM, MSc</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tej K Mattoo, MD, DCH, FRCP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne M Stack, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Globally, diarrheal disease remains one of the leading causes of childhood mortality and morbidity. Loss of intestinal fluid caused by gastroenteritis may lead to severe hypovolemia, shock, and death, particularly in children younger than five years of age in areas of the world with limited resources. In resource-abundant settings, such as the United States, diarrhea caused by gastroenteritis remains a major cause of hospitalizations.</p><p>Although the total number of deaths globally from diarrheal diseases from gastroenteritis remains high, the overall mortality rate has steadily declined over the last few decades. This decline, especially in resource-limited countries, is largely due to the early and appropriate use of oral rehydration therapy (ORT), improved nutrition and water sanitation measures, and effective vaccination for rotavirus. (See  <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings", section on 'Prevention'</a>.)</p><p>The composition of <a class="drug drug_pediatric" data-topicid="119967" href="/z/d/drug information/119967.html" rel="external">oral rehydration solutions</a> (ORS) and the clinical application of ORT in patients with diarrhea due to gastroenteritis are discussed in this topic review. Related content is available in these topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6142.html" rel="external">"Clinical assessment of hypovolemia (dehydration) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5992.html" rel="external">"Acute viral gastroenteritis in children in resource-abundant countries: Management and prevention"</a>.)</p><p></p><p>Material focused on children in resource-limited settings includes:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Dehydration'</a>.)</p><p></p><p class="headingAnchor" id="H405704614"><span class="h1">DEFINITIONS OF HYPOVOLEMIA AND DEHYDRATION</span><span class="headingEndMark"> — </span>The terms volume depletion (hypovolemia) and dehydration often are used interchangeably. However, these terms differentiate physiologic conditions resulting from different types of fluid loss. Much of the clinical literature does not differentiate between the two terms and uses them interchangeably. Thus, we will follow this convention and use the terms hypovolemia, volume depletion, and dehydration interchangeably as referring to all types of fluid deficits. (See  <a class="medical medical_review" href="/z/d/html/2307.html" rel="external">"General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)"</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PHYSIOLOGIC BASIS</span></p><p class="headingAnchor" id="H405705026"><span class="h2">Normal mechanisms for water absorption</span><span class="headingEndMark"> — </span>The following three principal mechanisms are responsible for passive intestinal water absorption (see  <a class="medical medical_review" href="/z/d/html/5860.html" rel="external">"Pathogenesis of acute diarrhea in children", section on 'Molecular mechanisms'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium/hydrogen (Na/H) exchangers</p><p class="bulletIndent1"><span class="glyph">●</span>Electrochemical gradient</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium-coupled transport with carrier organic solutes (eg, glucose)</p><p></p><p>Disruption of any of the above processes can result in diarrhea. However, in children with diarrhea due to gastroenteritis, the sodium-coupled co-transport with glucose and other carrier organic solutes remains intact [<a href="#rid1">1,2</a>].</p><p class="headingAnchor" id="H405707237"><span class="h2">Oral rehydration solution properties for water absorption</span><span class="headingEndMark"> — </span>Successful <a class="drug drug_pediatric" data-topicid="119967" href="/z/d/drug information/119967.html" rel="external">oral rehydration solutions</a> (ORS) take advantage of the preserved co-transport of glucose and sodium in patients with acute infectious diarrhea for water absorption. Studies from the 1960s reported that isotonic ORS formulations with equimolar concentrations of glucose and sodium are as effective as intravenous (IV) hydration in treating hypovolemia in patients with cholera [<a href="#rid1">1,2</a>]. Subsequent formulations have been designed based on this initial formulation  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3364918602"><span class="h3">Recommended composition</span><span class="headingEndMark"> — </span>The following properties for ORS are recommended by the World Health Organization (WHO) [<a href="#rid3">3</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Total osmolarity between 200 and 310 mOsm/L</p><p class="bulletIndent1"><span class="glyph">●</span>Equimolar concentrations of glucose and sodium</p><p class="bulletIndent1"><span class="glyph">●</span>Glucose concentration &lt;20 g/L (111 mmol/L)</p><p class="bulletIndent1"><span class="glyph">●</span>Sodium concentration between 60 and 90 mEq/L</p><p class="bulletIndent1"><span class="glyph">●</span>Potassium concentration between 15 and 25 mEq/L</p><p class="bulletIndent1"><span class="glyph">●</span>Citrate concentration between 8 and 12 mmol/L</p><p class="bulletIndent1"><span class="glyph">●</span>Chloride concentration between 50 and 80 mEq/L</p><p></p><p>Fluids with a molar ratio of glucose in excess of sodium (eg, fruit juices, soda, or sports beverages) have the theoretical potential of increasing diarrheal losses because the higher unabsorbed glucose load will increase the osmolarity in the lumen, resulting in decreased water absorption.</p><p>Fluids with excess sodium concentration compared with glucose (eg, chicken broth) may also increase diarrheal losses as there is no organic solute to facilitate the transport of sodium. On the other hand, fluids with excessively high sodium concentration may result in hypernatremia.</p><p class="headingAnchor" id="H405708009"><span class="h3">Osmolarity</span><span class="headingEndMark"> — </span>Several clinical trials and meta-analyses have demonstrated that the administration of solutions with lower osmolarity can reduce stool volume and the duration of diarrhea [<a href="#rid4">4,5</a>]. These findings led the WHO to reduce the recommended ORS formulation in 2002 from an osmolarity of 311 mOsm/L to 245 mOsm/L, as well as the concentrations of glucose from 20 g/L (111 mmol/L) to 13.5 g/L (75 mmol/L) and sodium from 90 to 75 mEq/L. The new formulation preserved the molar 1:1 ratio of sodium and glucose and is the only ORS used globally by the WHO.</p><p>Although there were concerns initially that the reduced-osmolarity ORS may result in hyponatremia for patients with cholera who often have diarrheal losses of sodium concentration of 90 to 120 mEq/L, a large observational study in Bangladesh reported that the incidence of symptomatic hyponatremia was rare in both children and adults [<a href="#rid6">6</a>]. Thus, reduced-osmolarity ORS is safe and can be used to treat most patients with acute diarrhea.</p><p>Rehydration Solution for Malnutrition (ReSoMal), which has a lower sodium and higher potassium content than traditional WHO ORS, was developed specifically for use in severely malnourished children. Its composition and use are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5901.html" rel="external">"Management of complicated severe acute malnutrition in children in resource-limited settings", section on 'Dehydration'</a>.)</p><p class="headingAnchor" id="H405708138"><span class="h3">Carrier organic solute</span></p><p class="bulletIndent1"><span class="glyph">●</span>Glucose – The WHO ORS formulation uses glucose as the carrier organic solute for sodium-coupled transport  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>). Although other alternative solutes have been studied (eg, zinc, prebiotics, glucose polymers, L-isoleucine) with some promising results, there are not conclusive data that they are more effective than glucose. Consequently, use of the WHO formulation containing 75 mEq/L of sodium and 75 mmol/L of glucose with an osmolarity of 245 mOsm/L water is still recommended.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Polymer-based formulations – Polymer-based ORS uses rice, wheat, and sorghum as a source of starch rather than glucose. Starch is broken down slowly into glucose molecules by amylase in the small intestine. A systematic review showed that the polymer-based ORS is more effective than high-osmolarity, glucose-based ORS (≥310 mOsm/L) in reducing stool volume and duration of diarrhea for patients with acute watery diarrhea due to cholera or other causes [<a href="#rid7">7</a>]. However, data were insufficient to show that polymer-based ORS is superior to glucose-based ORS with lower osmolarity (≤270 mOsm/L water).</p><p></p><p class="bulletIndent1">Until further data are available, we do <strong>not</strong> recommend initial use of polymer-based ORS either in resource-limited or resource-abundant settings, consistent with medical society guidance [<a href="#rid8">8</a>]. These formulations are not more effective than the standard WHO or commercial ORS, which are more readily available and less costly.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other carrier solutes – Formulations that use maltodextrins or rice, or add amino acids (glycine, alanine, and <a class="drug drug_pediatric" data-topicid="132253" href="/z/d/drug information/132253.html" rel="external">glutamine</a>) to glucose, are also <strong>not</strong> more effective than standard ORS and are more costly [<a href="#rid9">9-11</a>]. These formulations should <strong>not</strong> be routinely used.</p><p></p><p class="headingAnchor" id="H4"><span class="h1">EFFICACY</span><span class="headingEndMark"> — </span>ORT reduces childhood mortality from diarrheal disease [<a href="#rid12">12-14</a>]. This was best illustrated in a 2010 meta-analysis that included three low-quality studies showing diarrhea-specific mortality was lower in communities in which oral rehydration solution (ORS) was promoted compared with control communities without ORS promotion [<a href="#rid14">14</a>].</p><p>In addition, clinical trials and meta-analyses have shown that ORT is as effective as intravenous (IV) rehydration therapy in treating hypovolemia from diarrheal illness due to gastroenteritis [<a href="#rid15">15-23</a>]. ORT was also associated with a shorter length of hospitalization, lower costs, and fewer complications (eg, phlebitis).</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL MANAGEMENT</span><span class="headingEndMark"> — </span>ORT is the preferred first-line treatment of fluid and electrolyte losses caused by diarrhea due to gastroenteritis in children with mild to moderate dehydration [<a href="#rid15">15-23</a>]. It is used to treat hypovolemia caused by gastroenteritis independent of age, causative agent, or initial sodium values [<a href="#rid24">24</a>]. Advantages of ORT compared with intravenous (IV) hydration include that it is lower cost, easier to administer, a less invasive intervention that can be performed at home, and associated with a lower rate of revisits to the emergency department (ED) [<a href="#rid25">25</a>]. (See <a class="local">'Efficacy'</a> above.)</p><p class="headingAnchor" id="H405705466"><span class="h2">Setting</span><span class="headingEndMark"> — </span>ORT can be given either at home or in a medically supervised setting.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Home</strong> – If parents or caregivers are properly instructed to recognize the appropriate clinical signs of dehydration, ORT can be given at home, leading to fewer outpatient and ED visits [<a href="#rid26">26</a>]. A standard commercially prepared and premixed oral rehydration solution (ORS) is recommended for use in nonmedical settings because major errors can occur when homemade solutions using sugar and sodium are administered  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>) [<a href="#rid27">27</a>]. Parents and caregivers need to be educated on how to perform ORT and how to recognize signs of illness or treatment failure requiring medical attention [<a href="#rid28">28</a>]. Assessment of the patient at home with gastroenteritis is discussed elsewhere.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medically supervised setting</strong> – Prior to initiation of ORT, the child who presents to a medical clinician's office, ED, or urgent care facility with diarrhea should be evaluated to determine the underlying etiology of diarrhea and whether further diagnostic testing and/or intervention is necessary. (See  <a class="medical medical_review" href="/z/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1">If there is evidence that rehydration is appropriate, ORT using a standard commercial formulation should be initiated if the patient has mild to moderate hypovolemia and there are no contraindications to enteral therapy.</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Oral rehydration therapy based on degree of dehydration</span></p><p class="headingAnchor" id="H1554589336"><span class="h3">Assessment of dehydration</span><span class="headingEndMark"> — </span>Once the decision is made to begin hydration therapy, clinical assessment of the patient's hydration status is necessary as it guides clinical decisions in the use of ORT. The goal of hydration assessment for patients with diarrhea is to determine the fluid management approach for individuals, as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Identify patients who are not dehydrated and can be safely sent home with ORT maintenance</p><p class="bulletIndent1"><span class="glyph">●</span>Identify patients who are mildly to moderately dehydrated, in whom ORT is the preferred therapy for rehydration</p><p class="bulletIndent1"><span class="glyph">●</span>Identify patients who are severely dehydrated and require IV rehydration</p><p></p><p>Traditionally, attempts have been made to differentiate between mild and moderate hypovolemia  (<a class="graphic graphic_table graphicRef76198" href="/z/d/graphic/76198.html" rel="external">table 2</a>). However, in the clinical setting, it is difficult to distinguish between the two degrees of dehydration because the signs or symptoms overlap and encompass a relatively wide range of fluid deficits (ie, from 3 to 9 percent volume depletion) [<a href="#rid29">29</a>]. As a result, experts, including the author, group patients with mild to moderate dehydration together as "some" dehydration and manage them similarly. (See  <a class="medical medical_review" href="/z/d/html/6142.html" rel="external">"Clinical assessment of hypovolemia (dehydration) in children", section on 'Estimating degree of hypovolemia'</a>.)</p><p>The following sections outline recommendations for ORT based on guidelines from the Centers of Disease Control and Prevention (CDC), American Academy of Pediatrics (AAP), European Society for Paediatric Gastroenterology, Hepatology and Nutrition, and European Society for Paediatric Infectious Diseases [<a href="#rid8">8,28</a>]. These guidelines are based on data acquired from efficacy trials conducted in both resource-limited and resource-abundant settings.</p><p>Treatment is divided into two phases:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rehydration phase</strong> – The fluid deficit is replaced quickly over three to four hours, returning the patient to a euvolemic state. ORS is administered in frequent, small amounts by spoon or syringe. A nasogastric tube can be used in the child who refuses to drink [<a href="#rid28">28,30-32</a>]. Each aliquot given must be small enough to avoid accumulation of a large amount of fluid in the stomach that might trigger vomiting. Five mL (one teaspoon), administered every one to two minute, allows as much as 150 to 300 mL/hour to be given. If the patient is breastfed, breastfeeding continues during this phase as well as during the maintenance phase.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maintenance phase</strong> – Maintenance calories and fluids are administered. Rapid realimentation begins after completion of the rehydration phase, with the goal to return the patient to an age-appropriate unrestricted diet. (See  <a class="medical medical_review" href="/z/d/html/6122.html" rel="external">"Maintenance intravenous fluid therapy in children"</a>.)</p><p></p><p>During both phases, ongoing losses from diarrhea and vomiting are replaced with ORS. If the losses can be measured accurately, 1 mL of ORS should be administered for each gram of diarrheal stool. Alternatively, 10 mL/kg of body weight of ORS should be administered for each watery or loose stool and 2 mL/kg of body weight for each episode of emesis.</p><p class="headingAnchor" id="H9"><span class="h4">No dehydration</span><span class="headingEndMark"> — </span>For patients with diarrhea but no evidence of dehydration, ORT is used to maintain hydration by replacement of stool losses, as outlined above. If the stool output is minimal, ORS may not be required. Regardless of stool output, age-appropriate feeding (including breastfeeding) should be continued along with supplemental fluids. (See <a class="local">'Common household beverages and fluids'</a> below.)</p><p class="headingAnchor" id="H10"><span class="h4">Mild to moderate (some) dehydration</span><span class="headingEndMark"> — </span>While some individuals with lesser degrees of dehydration can be cared for at home once proper oral rehydration techniques have been taught, the care of patients with greater degrees of dehydration is best provided in a medically supervised setting.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Repletion phase</strong> – Hydration should be restored by administering ORS at a volume of 50 to 100 mL/kg over four hours. Additional ORS is given to replace ongoing gastrointestinal losses (eg, stool or emesis). Reassessment of the patient's hydration status and replacement of ongoing losses should occur hourly.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maintenance phase</strong> – Once repletion is completed, feeding and fluids should be started as discussed previously. ORT is continued for ongoing gastrointestinal losses. The patient's hydration status and ongoing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.</p><p></p><p class="headingAnchor" id="H12"><span class="h4">Severe dehydration</span><span class="headingEndMark"> — </span>Severe dehydration is defined as 10 percent or greater volume loss.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Repletion phase</strong> – Severe dehydration is a medical emergency and requires emergent IV therapy with rapid infusion of 20 mL/kg of an isotonic solution (eg, 0.9% NaCl, Plasmalyte, or <a class="drug drug_pediatric" data-topicid="108442" href="/z/d/drug information/108442.html" rel="external">lactated Ringer</a>). A more complete discussion regarding treatment of severe dehydration can be found in a separate topic review. (See  <a class="medical medical_review" href="/z/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings", section on 'Emergency fluid repletion phase'</a>.)</p><p></p><p class="bulletIndent1">As the patient's clinical condition stabilizes and their level of consciousness returns to normal, therapy can be changed to ORT. A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. The IV line should remain in place until it is certain that there is successful transition to ORT. ORS is started at a volume of 100 mL/kg over four hours or 25 mL/kg per hour. Additional ORS is given to replace ongoing gastrointestinal losses, as previously outlined. At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Maintenance phase</strong> – Once repletion is completed, feeding and fluids should be started, as discussed previously. ORT is continued for ongoing gastrointestinal losses [<a href="#rid4">4-6,9-11,21,33-45</a>].</p><p></p><p class="headingAnchor" id="H332589666"><span class="h3">Discharge from medical setting and return to home management</span><span class="headingEndMark"> — </span>Patients can be discharged from a medical setting and returned to home ORT management when the following endpoints are achieved [<a href="#rid28">28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A reasonable amount of ORT for the degree of dehydration has been successfully administered. Sufficient intake is reflected by normalization of vital signs, improved level of consciousness and activity, urine output (if there has been none for a prolonged period of time), and resolution of signs of dehydration. In addition, there is no evidence of intractable vomiting or ORS refusal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No concern for other possible illnesses that might complicate the clinical course.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>No social or logistical concerns that might prevent return evaluation, if necessary.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Caregivers have been sufficiently educated regarding the use of ORT at home and the criteria for return or need for further medical advice (eg, signs of dehydration).</p><p></p><p class="headingAnchor" id="H3612616124"><span class="h3">Contraindications to oral rehydration therapy</span><span class="headingEndMark"> — </span>There are clinical settings when ORT should <strong>not</strong> be used. These include in children with the following conditions:</p><p class="bulletIndent1"><span class="glyph">●</span>Altered mental status with concern for aspiration</p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal ileus</p><p class="bulletIndent1"><span class="glyph">●</span>Underlying disorder that limits intestinal absorption of ORT (eg, short gut, carbohydrate malabsorption)</p><p class="bulletIndent1"><span class="glyph">●</span>Severe dehydration (see <a class="local">'Severe dehydration'</a> above)</p><p></p><p>Once ORT has been initiated, intervention with IV hydration is indicated:</p><p class="bulletIndent1"><span class="glyph">●</span>If stool output continues to be excessive and ORT is unable to adequately rehydrate the child</p><p class="bulletIndent1"><span class="glyph">●</span>If there is severe and persistent vomiting and inadequate intake of ORS</p><p></p><p class="headingAnchor" id="H17"><span class="h2">Commercial and standard oral rehydration solutions</span><span class="headingEndMark"> — </span>Either the standard World Health Organization (WHO) or a commercially available ORS should be used for ORT. These solutions have equimolar concentration of glucose and sodium with osmolarity between 200 and 310 mOsm/L; the precise composition varies slightly, as summarized in the table  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>). Based on the available data, differences in the composition of commercially available products and the 2002 WHO ORS do not appear to be clinically significant when administered to children with diarrhea in resource-abundant settings.</p><p>All commercial ORS contain 2 to 3 percent carbohydrate as glucose, rice, or other cereal; this amount is sufficient to promote intestinal water absorption while avoiding a large osmotic load in the intestinal lumen. Studies in the United States demonstrated successful treatment with commonly used commercial ORS in children with mild to moderate dehydration [<a href="#rid21">21,36</a>]. In children between 5 and 10 years of age, sucralose-sweetened ORS solutions (eg, Pedialyte and Pediatric Electrolyte) appear to be more palatable than comparable rice-based solutions (eg, Enfalyte) and are appropriate ORS options [<a href="#rid46">46</a>]. (See <a class="local">'Oral rehydration solution properties for water absorption'</a> above.)</p><p class="headingAnchor" id="H3232641603"><span class="h2">Other therapeutic measures</span></p><p class="headingAnchor" id="H571930197"><span class="h3">Common household beverages and fluids</span><span class="headingEndMark"> — </span>Commonly used household fluids for children with gastroenteritis include gelatin, tea, fruit juice, sports drinks, and soft drinks. These fluids have much lower sodium concentration, and nearly all have a much higher carbohydrate and osmolarity content than commercial and standard ORS  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>). As a result, they have not been recommended as an alternative to commercial standard ORS for rehydration in children with gastroenteritis, because of concerns that they could induce osmotic diarrhea, resulting in hyponatremia. However, a Canadian clinical trial in children between 6 to 60 months of age with mild gastroenteritis and no clinical signs of dehydration demonstrated that half-strength apple juice (diluted 1:1 apple juice:water) compared with apple-flavored commercial standard ORS resulted in fewer episodes of treatment failure (17 versus 25 percent) [<a href="#rid47">47</a>]. In this single-center study, treatment failure was defined as any of the following events occurring within seven days of enrollment: IV rehydration, hospitalization, subsequent unscheduled clinician encounter, protracted symptoms, crossover to the other fluid, and 3 percent or more weight loss or signs of significant dehydration based on an in-person follow-up visit. Following ED discharge, the group assigned to half-strength apple juice were allowed to consume whatever fluids the children desired to replace ongoing losses and the ORS group continued with electrolyte maintenance solution. These results show that diluted apple juice followed by a permissive approach to fluids consumption can be used to maintain hydration in young children with mild gastroenteritis and minimal dehydration in high-income countries.</p><p>On the other hand, chicken soup, which has a high sodium concentration, may result in hypernatremia and should be avoided as a rehydration fluid source [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H405708678"><span class="h3">Zinc</span><span class="headingEndMark"> — </span>Zinc supplementation should be administered to children older than six months of age with diarrhea in resource-limited countries where there is a high prevalence of zinc deficiency [<a href="#rid48">48</a>]. Zinc supplementation in these settings is discussed in greater detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings", section on 'Vitamins and minerals'</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">Antiemetic therapy</span><span class="headingEndMark"> — </span>In patients with clinically significant vomiting, the use of the antiemetic <a class="drug drug_pediatric" data-topicid="12659" href="/z/d/drug information/12659.html" rel="external">ondansetron</a> has facilitated the administration of ORT by reducing vomiting [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/z/d/html/5992.html" rel="external">"Acute viral gastroenteritis in children in resource-abundant countries: Management and prevention", section on 'Antiemetic agents'</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Barriers to the use of oral rehydration therapy in resource-abundant settings</span><span class="headingEndMark"> — </span>Despite its universal success in low- and middle-income countries, ORT remains underutilized in many high-income countries, particularly in the United States. In a comparative analysis that included children with similarly severe episodes of acute gastroenteritis seeking ED care in the United States or Canada, revisit rates were similar despite lower rates of IV rehydration and hospitalization in Canadian EDs [<a href="#rid50">50</a>]. These findings demonstrate that there is likely room to further promote ORT in the United States.</p><p>Barriers to ORS utilization include:</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of compliance and knowledge by clinicians – Surveys conducted over the past two decades showed that clinicians had insufficient knowledge regarding ORT and did not follow guidelines developed by the AAP or CDC on the appropriate use of ORT in patients with hypovolemia due to gastroenteritis [<a href="#rid41">41-43</a>]. In a 2011 survey, 44 of the 94 pediatric emergency clinicians from the United States (47 percent) reported using ORT as initial therapy in children with moderate dehydration compared with 103 of 136 Canadian clinicians (76 percent) [<a href="#rid51">51</a>]. This may reflect findings from an early report of American emergency clinicians who preferred IV hydration to ORT in treating moderate dehydration in children with gastroenteritis, even among those who indicated familiarity with the guidelines promoting ORT [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">These results demonstrate the need for continued efforts to educate clinicians on the benefits of ORT over IV hydration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Expense – The cost of commercially available ORS may limit its use at home in low-socioeconomic families [<a href="#rid44">44</a>]. As noted above, diluted apple juice and other fluids routinely consumed by children are reasonable options for children with mild gastroenteritis and no clinical symptoms of dehydration. (See <a class="local">'Common household beverages and fluids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Public access to inaccurate information – There was one case report of a child whose care was compromised by following advice to use nonphysiologic fluids at a decreased rate from a hospital's internet site [<a href="#rid45">45</a>].</p><p></p><p class="headingAnchor" id="H1364018354"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/127479.html" rel="external">"Society guideline links: Fluid and electrolyte disorders in children"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/16587.html" rel="external">"Patient education: Giving your child over-the-counter medicines (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16940.html" rel="external">"Patient education: Dehydration in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/1202.html" rel="external">"Patient education: Acute diarrhea in children (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H22"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Benefits of oral rehydration therapy (ORT)</strong> – We recommend ORT as the initial treatment for most patients with mild to moderate (some) hypovolemia due to gastroenteritis  (<a class="graphic graphic_table graphicRef76198" href="/z/d/graphic/76198.html" rel="external">table 2</a>) (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). ORT is as effective as intravenous (IV) hydration to treat hypovolemia in patients with gastroenteritis but is less invasive and costly and easier to administer. (See <a class="local">'Efficacy'</a> above and <a class="local">'Oral rehydration therapy based on degree of dehydration'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ORT formulations</strong> – We suggest that a standard, commercially prepared oral rehydration solution (ORS) or one available from the World Health Organization (WHO), which has equimolar concentrations of glucose and sodium and an osmolarity between 200 and 310 mOsm/L, be used for ORT in children with clinical signs of dehydration  (<a class="graphic graphic_table graphicRef67494" href="/z/d/graphic/67494.html" rel="external">table 1</a>) (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). However, for children with mild gastroenteritis and no clinical signs of dehydration, half-strength apple juice is a reasonable option for ORT. Homemade solutions that use sugar and sodium should not be used, because of the risk of major errors. (See <a class="local">'Oral rehydration solution properties for water absorption'</a> above and <a class="local">'Setting'</a> above and <a class="local">'Common household beverages and fluids'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraindications to ORT</strong> – ORT is contraindicated in patients with impaired mental status at risk for aspiration, abdominal ileus or other conditions that preclude adequate fluid absorption from the intestinal tract, severe hypovolemia, or persistent vomiting. IV hydration should be administrated to patients with these conditions as well as to those with dehydration who fail ORT. In patients with severe dehydration, emergent IV therapy is required with rapid infusion of 20 mL/kg of isotonic <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">saline</a> or a balanced crystalloid solution. Once the patient is stable, ORT can be started. (See  <a class="medical medical_review" href="/z/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Implementation</strong> – We recommend dividing ORT into rehydration and maintenance phases for patients with gastroenteritis and mild or moderate dehydration (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). In both phases, ongoing losses from diarrhea and vomiting are replaced with ORS. (See <a class="local">'Oral rehydration therapy based on degree of dehydration'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Rehydration</strong> – In patients with mild or moderate hypovolemia, ORS is administrated in frequent, small amounts, no more than 5 mL administered every one to two minutes by spoon or syringe, for a total volume of 50 to 100 mL/kg replaced quickly over three to four hours. If the patient is breastfed, breastfeeding is maintained during the rehydration phase and is continued into the maintenance phase.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintenance</strong> – During the maintenance phase, maintenance calories and fluids are administered to replace ongoing losses. Rapid realimentation begins after completion of the rehydration phase, with the goal to return the patient to an age-appropriate, unrestricted diet.</p><p></p><p class="headingAnchor" id="H433708981"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Bonita Stanton, MD, Joshua B Evans, MD, and Bobby Batra, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hirschhorn N, Kinzie JL, Sachar DB, et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med 1968; 279:176.</a></li><li><a class="nounderline abstract_t">Pierce NF, Sack RB, Mitra RC, et al. Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med 1969; 70:1173.</a></li><li class="breakAll">World Health Organization. Reduced osmolarity oral rehydration salts (ORS) formulation. UNICEF House, New York, NY 2001. Available at: www.who.int/child-adolescent-health/New_Publications/NEWS/Expert_consultation.htm (Accessed on January 18, 2006).</li><li><a class="nounderline abstract_t">Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review. BMJ 2001; 323:81.</a></li><li><a class="nounderline abstract_t">Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev 2002; :CD002847.</a></li><li><a class="nounderline abstract_t">Alam NH, Yunus M, Faruque AS, et al. Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration solution. JAMA 2006; 296:567.</a></li><li><a class="nounderline abstract_t">Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev 2016; 12:CD006519.</a></li><li><a class="nounderline abstract_t">Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59:132.</a></li><li><a class="nounderline abstract_t">Duggan C, Fontaine O, Pierce NF, et al. Scientific rationale for a change in the composition of oral rehydration solution. JAMA 2004; 291:2628.</a></li><li><a class="nounderline abstract_t">Bhan MK, Mahalanabis D, Fontaine O, Pierce NF. Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ 1994; 72:945.</a></li><li><a class="nounderline abstract_t">Nalin DR, Cash RA, Rahman M, Yunus M. Effect of glycine and glucose on sodium and water adsorption in patients with cholera. Gut 1970; 11:768.</a></li><li><a class="nounderline abstract_t">Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78:1246.</a></li><li><a class="nounderline abstract_t">Mahalanabis D, Choudhuri AB, Bagchi NG, et al. Oral fluid therapy of cholera among Bangladesh refugees. Johns Hopkins Med J 1973; 132:197.</a></li><li><a class="nounderline abstract_t">Munos MK, Walker CL, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol 2010; 39 Suppl 1:i75.</a></li><li><a class="nounderline abstract_t">Tamer AM, Friedman LB, Maxwell SR, et al. Oral rehydration of infants in a large urban U.S. medical center. J Pediatr 1985; 107:14.</a></li><li><a class="nounderline abstract_t">Listernick R, Zieserl E, Davis AT. Outpatient oral rehydration in the United States. Am J Dis Child 1986; 140:211.</a></li><li><a class="nounderline abstract_t">Santosham M, Daum RS, Dillman L, et al. Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med 1982; 306:1070.</a></li><li><a class="nounderline abstract_t">Vesikari T, Isolauri E, Baer M. A comparative trial of rapid oral and intravenous rehydration in acute diarrhoea. Acta Paediatr Scand 1987; 76:300.</a></li><li><a class="nounderline abstract_t">Atherly-John YC, Cunningham SJ, Crain EF. A randomized trial of oral vs intravenous rehydration in a pediatric emergency department. Arch Pediatr Adolesc Med 2002; 156:1240.</a></li><li><a class="nounderline abstract_t">Fonseca BK, Holdgate A, Craig JC. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med 2004; 158:483.</a></li><li><a class="nounderline abstract_t">Spandorfer PR, Alessandrini EA, Joffe MD, et al. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics 2005; 115:295.</a></li><li><a class="nounderline abstract_t">Freedman SB, Ali S, Oleszczuk M, et al. Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries. Evid Based Child Health 2013; 8:1123.</a></li><li><a class="nounderline abstract_t">Hartling L, Bellemare S, Wiebe N, et al. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev 2006; :CD004390.</a></li><li><a class="nounderline abstract_t">Stanton BF, Rowland MG, Clemens JD. Oral rehydration solution--too little or too much? Lancet 1987; 1:33.</a></li><li><a class="nounderline abstract_t">Freedman SB, Thull-Freedman JD, Rumantir M, et al. Emergency department revisits in children with gastroenteritis. J Pediatr Gastroenterol Nutr 2013; 57:612.</a></li><li><a class="nounderline abstract_t">Duggan C, Lasche J, McCarty M, et al. Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits. Pediatrics 1999; 104:e29.</a></li><li><a class="nounderline abstract_t">Meyers A, Sampson A, Saladino R, et al. Safety and effectiveness of homemade and reconstituted packet cereal-based oral rehydration solutions: a randomized clinical trial. Pediatrics 1997; 100:E3.</a></li><li><a class="nounderline abstract_t">King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52:1.</a></li><li><a class="nounderline abstract_t">Freedman SB, Vandermeer B, Milne A, et al. Diagnosing clinically significant dehydration in children with acute gastroenteritis using noninvasive methods: a meta-analysis. J Pediatr 2015; 166:908.</a></li><li><a class="nounderline abstract_t">Mackenzie A, Barnes G. Randomised controlled trial comparing oral and intravenous rehydration therapy in children with diarrhoea. BMJ 1991; 303:393.</a></li><li><a class="nounderline abstract_t">Gremse DA. Effectiveness of nasogastric rehydration in hospitalized children with acute diarrhea. J Pediatr Gastroenterol Nutr 1995; 21:145.</a></li><li><a class="nounderline abstract_t">Nager AL, Wang VJ. Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration. Pediatrics 2002; 109:566.</a></li><li><a class="nounderline abstract_t">Fayad IM, Hirschhorn N, Abu-Zikry M, Kamel M. Hypernatraemia surveillance during a national diarrhoeal diseases control project in Egypt. Lancet 1992; 339:389.</a></li><li><a class="nounderline abstract_t">Gore SM, Fontaine O, Pierce NF. Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ 1992; 304:287.</a></li><li><a class="nounderline abstract_t">Nalin DR, Hirschhorn N, Greenough W 3rd, et al. Clinical concerns about reduced-osmolarity oral rehydration solution. JAMA 2004; 291:2632.</a></li><li><a class="nounderline abstract_t">Cohen MB, Mezoff AG, Laney DW Jr, et al. Use of a single solution for oral rehydration and maintenance therapy of infants with diarrhea and mild to moderate dehydration. Pediatrics 1995; 95:639.</a></li><li><a class="nounderline abstract_t">Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med 2006; 354:1698.</a></li><li><a class="nounderline abstract_t">Roslund G, Hepps TS, McQuillen KK. The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial. Ann Emerg Med 2008; 52:22.</a></li><li><a class="nounderline abstract_t">DeCamp LR, Byerley JS, Doshi N, Steiner MJ. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med 2008; 162:858.</a></li><li><a class="nounderline abstract_t">Ozuah PO, Avner JR, Stein RE. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics 2002; 109:259.</a></li><li><a class="nounderline abstract_t">Conners GP, Barker WH, Mushlin AI, Goepp JG. Oral versus intravenous: rehydration preferences of pediatric emergency medicine fellowship directors. Pediatr Emerg Care 2000; 16:335.</a></li><li><a class="nounderline abstract_t">Snyder JD. Use and misuse of oral therapy for diarrhea: comparison of US practices with American Academy of Pediatrics recommendations. Pediatrics 1991; 87:28.</a></li><li><a class="nounderline abstract_t">Reis EC, Goepp JG, Katz S, Santosham M. Barriers to use of oral rehydration therapy. Pediatrics 1994; 93:708.</a></li><li><a class="nounderline abstract_t">Meyers A, Siegel B, Vinci R. Economic barriers to the use of oral rehydration therapy. A case report. JAMA 1991; 265:1724.</a></li><li><a class="nounderline abstract_t">Crocco AG, Villasis-Keever M, Jadad AR. Two wrongs don't make a right: harm aggravated by inaccurate information on the Internet. Pediatrics 2002; 109:522.</a></li><li><a class="nounderline abstract_t">Freedman SB, Cho D, Boutis K, et al. Assessing the palatability of oral rehydration solutions in school-aged children: a randomized crossover trial. Arch Pediatr Adolesc Med 2010; 164:696.</a></li><li><a class="nounderline abstract_t">Freedman SB, Willan AR, Boutis K, Schuh S. Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis: A Randomized Clinical Trial. JAMA 2016; 315:1966.</a></li><li><a class="nounderline abstract_t">Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2016; 12:CD005436.</a></li><li><a class="nounderline abstract_t">Niño-Serna LF, Acosta-Reyes J, Veroniki AA, Florez ID. Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis. Pediatrics 2020; 145.</a></li><li><a class="nounderline abstract_t">Freedman SB, Roskind CG, Schuh S, et al. Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States. Pediatrics 2021; 147.</a></li><li><a class="nounderline abstract_t">Freedman SB, Sivabalasundaram V, Bohn V, et al. The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns. Acad Emerg Med 2011; 18:38.</a></li></ol></div><div id="topicVersionRevision">Topic 6129 Version 43.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4968807" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5789507" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5789507" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11451782" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Reduced osmolarity oral rehydration solution for treating dehydration due to diarrhoea in children: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869639" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16882963" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Symptomatic hyponatremia during treatment of dehydrating diarrheal disease with reduced osmolarity oral rehydration solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27959472" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Polymer-based oral rehydration solution for treating acute watery diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24739189" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15173155" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Scientific rationale for a change in the composition of oral rehydration solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7867142" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical trials of improved oral rehydration salt formulations: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5473608" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effect of glycine and glucose on sodium and water adsorption in patients with cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11100619" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reducing deaths from diarrhoea through oral rehydration therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4698667" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Oral fluid therapy of cholera among Bangladesh refugees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20348131" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4009330" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Oral rehydration of infants in a large urban U.S. medical center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3080871" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Outpatient oral rehydration in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7040950" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3296629" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A comparative trial of rapid oral and intravenous rehydration in acute diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12444837" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A randomized trial of oral vs intravenous rehydration in a pediatric emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15123483" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15687435" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23877938" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16856044" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2879103" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Oral rehydration solution--too little or too much?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23820403" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Emergency department revisits in children with gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10469812" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9346997" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Safety and effectiveness of homemade and reconstituted packet cereal-based oral rehydration solutions: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14627948" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25641247" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Diagnosing clinically significant dehydration in children with acute gastroenteritis using noninvasive methods: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1789830" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Randomised controlled trial comparing oral and intravenous rehydration therapy in children with diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7472899" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effectiveness of nasogastric rehydration in hospitalized children with acute diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11927697" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Comparison of nasogastric and intravenous methods of rehydration in pediatric patients with acute dehydration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1346660" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Hypernatraemia surveillance during a national diarrhoeal diseases control project in Egypt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1531430" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15173156" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Clinical concerns about reduced-osmolarity oral rehydration solution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724298" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Use of a single solution for oral rehydration and maintenance therapy of infants with diarrhea and mild to moderate dehydration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16625009" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Oral ondansetron for gastroenteritis in a pediatric emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18006189" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who have failed oral rehydration therapy: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18762604" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11826204" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Oral rehydration, emergency physicians, and practice parameters: a national survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11063362" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Oral versus intravenous: rehydration preferences of pediatric emergency medicine fellowship directors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1984614" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Use and misuse of oral therapy for diarrhea: comparison of US practices with American Academy of Pediatrics recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8165066" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Barriers to use of oral rehydration therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2002575" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Economic barriers to the use of oral rehydration therapy. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11875153" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Two wrongs don't make a right: harm aggravated by inaccurate information on the Internet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20679159" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Assessing the palatability of oral rehydration solutions in school-aged children: a randomized crossover trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27131100" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effect of Dilute Apple Juice and Preferred Fluids vs Electrolyte Maintenance Solution on Treatment Failure Among Children With Mild Gastroenteritis: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27996088" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Oral zinc for treating diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32132152" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34016656" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Comparing Pediatric Gastroenteritis Emergency Department Care in Canada and the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21182566" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
